11 July 2019

Director/PDMR Dealing

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that 2,500,000 options (“Options”) over the ordinary shares of 1p each in the share capital of the Company (“Ordinary Shares”) were granted to Directors and Persons Discharging Managerial Responsibilities on 10 July 2019.

The Options, which will vest in three equal tranches over three years, have an exercise period of ten years from grant and have an exercise price per Option of 3.85p. The Options vest in full upon the closing middle market price per Ordinary Share achieving 10p and positive cash flows from operations being sustained for any period of six months following date of grant.  

 

Director/PDMR Position Number of
Ordinary
Shares options granted
Lou Ruggiero Chief Business Officer 1,000,000
Kevin Darling  PDMR / VP Tissue Products    750,000
Chris Wattengel PDMR / VP Global R&D    750,000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name
  1. Lou Ruggiero
  2. Kevin Darling
  3. Christian Wattengel
2 Reason for the notification
a) Position/status
  1. Chief Business Officer
  2. PDMR / VP Tissue Products
  3. PDMR / VP Global R&D
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Collagen Solutions plc
b) LEI 213800IFY1CVGRGETL95
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1p each

ISIN Code: GB00B94T6Y14
b) Nature of the transaction Grant of options over ordinary shares of 1p each exercisable at 3.85p
c) Price(s) and volume(s)
Price (s) Volume(s)
1. 0p per share 1,000,000
2. 0p per share     750,000
3. 0p per share     750,000
d) Aggregated information - Aggregated volume - Price 2,500,000 N/a
e) Date of the transaction 10 July 2019
f) Place of the transaction Outside a trading venue

 

 

Enquiries:

Collagen Solutions Plc Contact via Walbrook
Jamal Rushdy, CEO  
Hilary Spence, CFO  
   
Cenkos Securities Plc (Nominated Adviser and Broker) Tel: 0207 397 8900
Giles Balleny / Stephen Keys  
   
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001